Abstract
With the continuous improvement of computer performance and related technology, the combination of molecular communication networks (MCN) and artificial intelligence (AI) can find the prediction to analyze target methods that are molecular diagnosis (MD) and more efficient. To overcome this issue, researchers have suggested the novel paradigm of the MD that combines nanoparticles-medicine (NPs-M) with tools from synthetic biology to provide re-engineering of biological computing devices. Here, in this work, the prediction model of the target is established by combining the drug calculation model of MCN and deep neural network (DNN) including classification performance for prediction. We developed a numerical analysis model to refer to drug target scalability (DTS), on a genome-wide scale based on protein to protein interaction (PPI) such as in-term of cardiac-disease. Finally, the prediction of the strength and direction of binding affinity between drugs and targets is achieved. Furthermore, to expand the application of the model, with a combination of genetic databases, the micro-processes related to genes are displayed. Then, to combine medicine, a multi-layer network is established based on the effect on/off mechanism. We establish a systematic MCN evaluation model that reveals the basis of MD of medicine and serves for screening, reorientation, drug development, and other fields of medical healthcare industries (MHI). The engineering finding demonstrates that the integration of phenotypic, chemical index in the NPs-M and PPI cannot only achieve scalability but also finds new applications for an existing drug.
Similar content being viewed by others
Change history
14 May 2022
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1007/s11051-022-05483-7
References
Anurogo D, Parikesit AA, Ikrar T (2017) Bionanomedicine: a “Panacea” in medicine? Makara J Health Res 21(2):2
Banerjee A, Chakraborty C, Kumar A, & Biswas D (2020). Emerging trends in IoT and big data analytics for biomedical and health care technologies. In Handbook of data science approaches for biomedical engineering (pp. 121-152). Academic Press.
Barabási AL, Gulbahce N, Loscalzo J (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12(1):56–68
Bonaccorso A (2018). Nanocarriers for nose-to-brain delivery: a novel strategy for the treatment of CNS disorders.
Brocheler M, Mihalkova L, and Getoor L. (2012) “Probabilistic similarity logic.” arXiv preprint arXiv:1203.3469.
Bruford EA et al (2007) The HGNC Database in 2008: a resource for the human genome. Nucleic Acids Res 36(suppl_1):D445–D448
Bruijnincx PCA, Sadler PJ (2009) Controlling platinum, ruthenium, and osmium reactivity for anticancer drug design. Adv Inorg Chem 61:1–62
Chang R, Shoemaker R, Wang W (2011) Systematic search for recipes to generate induced pluripotent stem cells. PLoS Comput Biol 7(12):e1002300
Cheng F et al (2012) Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput Biol 8(5):e1002503
Consortium UP (2015) UniProt: a hub for protein information. Nucleic Acids Res 43(D1):D204–D212
Dean B, Moller HJ, Svensson TH, Geyer MA, Rujescu D, Scarr E, Millan MJ (2014) Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think Tank. Int J Neuropsychopharmacol 17(1):137–148
Fakhraei S, Huang B, and Getoor L. 2013 “Collective inference and multi-relational learning for drugtarget interaction prediction.” NIPS Workshop Mach Learn Comput Biol (MLCB).
Gene Ontology Consortium (2004) The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 32(suppl_1):D258–D261
Getoor L, Diehl CP (2005) Link mining: a survey. Acm Sigkdd Explor Newslett 7(2):3–12
Griffioen AW, Molema G (2000) Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52(2):237–268
Hamosh A, Scott AF, Amberger J, Valle D, McKusick VA (2000) Online Mendelian inheritance in man (OMIM). Hum Mutat 15(1):57–61
Junejo AR et al (2019) Molecular diagnostic and using deep learning techniques for predict functional recovery of patients treated of cardiovascular disease. IEEE Access 7:120315–120325
Junejo AR, Memon S, Pathan S (2016) A novel precursor in preparation and characterization of nickel oxide (NIO) and cobalt oxide (CO3O4) nanoparticles (NPS) via aqueous chemical growth (ACG) techniques. AdvNanosci Technol: an Internation al Journal (ANTJ) 2(1):1–7
Kennard RW, Stone LA (1969) Computer aided design of experiments. Technometrics 11(1):137–148
Ketkar N, Santana E (2017) Deep Learning with Python, vol 1. Apress, Berkeley
Kim S et al (2016) PubChem substance and compound databases. Nucleic Acids Res 44(D1):D1202–D1213
Kimmig A, et al. (2012) “A short introduction to probabilistic soft logic.” Proceedings of the NIPS Workshop on Probabilistic Programming: Foundations and Applications.
Li, S. 1999. “Possible relationship between traditional Chinese medicine ZHENG and molecular networks.” Proc 1st Acad Ann Meet China Assoc Sci Technol.
Li S (2007). Framework and practice of network-based studies for Chinese herbal formula.
Li S (2009) Network systems underlying traditional Chinese medicine syndrome and herb formula. Curr Bioinforma 4(3):188–196
Li S (2015) Mapping ancient remedies: applying a network approach to traditional Chinese medicine. Science 350(6262):S72–S74
Li S, Zhang B, Zhang N (2011) Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Syst Biol 5(S1):S10
Lin D. (1998) “An information-theoretic definition of similarity.” Icml. Vol. 98. No. 1998. .
Liu Z et al (2011) Link prediction in complex networks: A local naïve Bayes model. EPL (Europhysics Letters) 96(4):48007
Liu T et al BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities. Nucleic Acids Res 35(2017, suppl_1):D198–D201
MacNamee B. (2004) “Proactive Persistent Agents.” Using Situational Intelligence to Create Support Characters in Character-Centric Computer Games.
McNamara K, Tofail SA (2015) Nanosystems: the use of nanoalloys, metallic, bimetallic, and magnetic nanoparticles in biomedical applications. Phys Chem Chem Phys 17(42):27981–27995
Oliveira ON Jr, Iost RM, Siqueira JR Jr, Crespilho FN, Caseli L (2014) Nanomaterials for diagnosis: challenges and applications in smart devices based on molecular recognition. ACS Appl Mater Interfaces 6(17):14745–14766
Öztürk H, Özgür A, Ozkirimli E (2018) DeepDTA: deep drug–target binding affinity prediction. Bioinformatics 34(17):i821–i829
Patra JK, Das G, Fraceto LF, Campos EVR, del Pilar Rodriguez-Torres M, Acosta-Torres LS, Shin HS (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol 16(1):71
Perumal V, Sivakumar PM, Zarrabi A, Muthupandian S, Vijayaraghavalu S, Sahoo K, Das A, Das S, Payyappilly SS, Das S (2019) Near infra-red polymeric nanoparticle based optical imaging in cancer diagnosis. J Photochem Photobiol B Biol 199:111630
Reeke GN, Sporns O, Edelman GM (1990) Synthetic neural modeling: the ‘Darwin’ series of recognition automata. Proc IEEE 78(9):1498–1530
Shao LI, Zhang B (2013) Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med 11(2):110–120
Tolios A, de Las Rivas J, Hovig E, Trouillas P, Scorilas A, Mohr T (2020) Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions. Drug Resist Updat 48:100662
Ventola CL (2017) Progress in nanomedicine: approved and investigational nanodrugs. Pharm Ther 42(12):742–755
Wang XJ, Ren JL, Zhang AH, Sun H, Yan GL, Han Y, Liu L (2019) Novel applications of mass spectrometry-based metabolomics in herbal medicines and its active ingredients: current evidence. Mass Spectrom Rev 38(4-5):380–402
Wang DD, Zhu M, and Yan H. (2020a). “Computationally predicting binding affinity in protein–ligand complexes: free energy-based simulations and machine learning-based scoring functions.” Briefings in Bioinformatics
Wang E, et al. (2020b). “Development and evaluation of MM/GBSA based on a variable dielectric GB model for predicting protein–ligand binding affinities.” J Chem Inform Model
Watkins J, Marsh A, Taylor PC, Singer DR (2010) Personalized medicine: the impact on chemistry. Ther Deliv 1(5):651–665
Weininger D (1988) SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J Chem Inf Comput Sci 28(1):31–36
Wen M, Zhang Z, Niu S, Sha H, Yang R, Yun Y, Lu H (2017) Deep-learning-based drug-target interaction prediction. J Proteome Res 16(4):1401–1409
Willett P, Winterman V, Bawden D (1986) Implementation of nearest-neighbor searching in an online chemical structure search system. J Chem Inf Comput Sci 26(1):36–41
Wishart DS, Wu A (2016) Using DrugBank for in silico drug exploration and discovery. Curr Protoc Bioinformatics 54(1):14–14
Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur, D.,& Hassanali, M. (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36(suppl_1):D901–D906
Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, le D, Pon A, Knox C, Wilson M, Wilson M (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 46(D1):D1074–D1082
Wu T, Yue R, Li L, He M (2020) Study on the mechanisms of Banxia Xiexin decoction in treating diabetic gastroparesis based on network pharmacology. Interdisc Sci: Computational Life Sciences 12(4):487–498
Yamanishi Y, Araki M, Gutteridge A, Honda W, Kanehisa M (2008) Prediction of drug–target interaction networks from the integration of chemical and genomic spaces. Bioinformatics 24(13):i232–i240
Zhao S, Li S (2010) Network-based relating pharmacological and genomic spaces for drug target identification. PLoS One 5(7):e11764
Zheng X, et al. (2013)“Collaborative matrix factorization with multiple similarities for predicting drug-target interactions.” Proceedings of the 19th ACM SIGKDD international conference on Knowledge discovery and data mining.
Zitnik M, Agrawal M, Leskovec J (2018) Modeling polypharmacy side effects with graph convolutional networks. Bioinformatics 34(13):i457–i466
Acknowledgements
We would like to express our great appreciation to the Deep learning laboratory at Harbin Institute of Technology. We also want to thank all the members in laboratories for their technical insights, stimulating ideas, and hard work in data collecting and experimental work, which greatly contributed to the success of our research.
Funding
This research work was supported by the National Natural Science Foundation of China under (No.61100029).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed especially nanoparticles medicine by AR Junejo, and Xiang Li. The first draft of the manuscript was written by Hina Madiha, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article has been retracted. Please see the retraction notice for more detail:https://doi.org/10.1007/s11051-022-05483-7
About this article
Cite this article
Junejo, A.R., Li, X., Madiha, H. et al. RETRACTED ARTICLE: Molecular communication networks: drug target scalability based on artificial intelligence prediction techniques. J Nanopart Res 23, 75 (2021). https://doi.org/10.1007/s11051-021-05181-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-021-05181-w